Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Rinaldi

Showing results (121-130 of 131) with videos related to

Pageof 14
Sort By:
Journal of Pharmaceutical and Biomedical Analysis|March 19, 2019
Development of an integrated chromatographic system for ω-transaminase-IMER characterization useful for flow-chemistry applicationsM Corti, F Rinaldi, D Monti, et al.
Cell Death & Disease|January 25, 2014
Cross-regulation of Connexin43 and β-catenin influences differentiation of human neural progenitor cellsF Rinaldi, E M Hartfield, L A Crompton, et al.
Colloids and Surfaces. B, Biointerfaces|July 27, 2015
Bioconjugation of gold-polymer core-shell nanoparticles with bovine serum amine oxidase for biomedical applicationsI Venditti, T F Hassanein, I Fratoddi, et al.
Digestive Diseases and Sciences|January 1, 1983
Percutaneous blind biopsy versus laparoscopy with guided biopsy in diagnosis of cirrhosis. A prospective, randomized trialL Pagliaro, F Rinaldi, A Craxì, et al.
International Journal of Pharmaceutics|August 8, 2016
Niosomal approach to brain delivery: Development, characterization and in vitro toxicological studiesC Ingallina, F Rinaldi, A Bogni, et al.
Multiple Sclerosis and Related Disorders|January 7, 2024
Blood-brain barrier damage associates with glia-related cytokines in the cerebrospinal fluid of patients with Multiple SclerosisM Puthenparampil, A Marin, G Zanotelli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 13, 2013
Natalizumab in pediatric multiple sclerosis: results of a cohort of 55 casesA Ghezzi, C Pozzilli, L M E Grimaldi, et al.
Environment International|June 18, 2026
Multi-mycotoxin biomonitoring in Italian adults: Revealing the connection between diet habits and mycotoxin exposureOctavian Augustin Mihalache, Cristiana Mignogna, Raquel Torrijos, et al.
Minerva Medica|August 18, 1978
[Immunological aspects of primary carcinoma of the liver]M Amuso, M Cottone, G D'Amico, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|May 16, 2012
Urinary JCV-DNA testing during natalizumab treatment may increase accuracy of PML risk stratificationA Laroni, C G Giacomazzi, L Grimaldi, et al.
Pageof 14

Showing results (121-130 of 131) with videos related to

Sort By:
Pageof 14
Journal of Pharmaceutical and Biomedical Analysis|March 19, 2019
Development of an integrated chromatographic system for ω-transaminase-IMER characterization useful for flow-chemistry applicationsM Corti, F Rinaldi, D Monti, et al.
Cell Death & Disease|January 25, 2014
Cross-regulation of Connexin43 and β-catenin influences differentiation of human neural progenitor cellsF Rinaldi, E M Hartfield, L A Crompton, et al.
Colloids and Surfaces. B, Biointerfaces|July 27, 2015
Bioconjugation of gold-polymer core-shell nanoparticles with bovine serum amine oxidase for biomedical applicationsI Venditti, T F Hassanein, I Fratoddi, et al.
Digestive Diseases and Sciences|January 1, 1983
Percutaneous blind biopsy versus laparoscopy with guided biopsy in diagnosis of cirrhosis. A prospective, randomized trialL Pagliaro, F Rinaldi, A Craxì, et al.
International Journal of Pharmaceutics|August 8, 2016
Niosomal approach to brain delivery: Development, characterization and in vitro toxicological studiesC Ingallina, F Rinaldi, A Bogni, et al.
Multiple Sclerosis and Related Disorders|January 7, 2024
Blood-brain barrier damage associates with glia-related cytokines in the cerebrospinal fluid of patients with Multiple SclerosisM Puthenparampil, A Marin, G Zanotelli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 13, 2013
Natalizumab in pediatric multiple sclerosis: results of a cohort of 55 casesA Ghezzi, C Pozzilli, L M E Grimaldi, et al.
Environment International|June 18, 2026
Multi-mycotoxin biomonitoring in Italian adults: Revealing the connection between diet habits and mycotoxin exposureOctavian Augustin Mihalache, Cristiana Mignogna, Raquel Torrijos, et al.
Minerva Medica|August 18, 1978
[Immunological aspects of primary carcinoma of the liver]M Amuso, M Cottone, G D'Amico, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|May 16, 2012
Urinary JCV-DNA testing during natalizumab treatment may increase accuracy of PML risk stratificationA Laroni, C G Giacomazzi, L Grimaldi, et al.
Pageof 14